Andrew Spencer, Marc-Steffen Raab, Shinsuke Iida, María-Victoria Mateos Manteca, Michele Cavo, Paula Rodriguez-Otero, P. Joy Ho, Yunxin Chen, Paul Ferguson, Irit Avivi, Paolo Corradini, Esther Chan, Andy Chen, Bertrand Arnulf, Udo Holtick, Adam Sperling, Jufen Chu, David Pearson, Davide Germano, Ronan Feighery, Nikhil Munshi
OA-12 Interim Phase 2 Study Results of Durcabtagene Autoleucel (PHE885), a T-Charge™ Manufactured BCMA-Directed CAR-T Cell Therapy in Patients (pts) with r/r Multiple Myeloma (RRMM)
期刊介绍:
Clinical Lymphoma, Myeloma & Leukemia is a peer-reviewed monthly journal that publishes original articles describing various aspects of clinical and translational research of lymphoma, myeloma and leukemia. Clinical Lymphoma, Myeloma & Leukemia is devoted to articles on detection, diagnosis, prevention, and treatment of lymphoma, myeloma, leukemia and related disorders including macroglobulinemia, amyloidosis, and plasma-cell dyscrasias. The main emphasis is on recent scientific developments in all areas related to lymphoma, myeloma and leukemia. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.